Myofibroblasts are primary effector cells in pulmonary fibrosis progression and exhibit a higher proliferation rate and contractile phenotype, causing overexpression of fibronectin (Fn), collagen I (Col I), and α-smooth muscle actin (α-SMA) (Sgalla et al., 2018). Here, FN1 is linked to pulmonary fibrosis.